Lifestance Health Group Inc (LFST) Stock Price, Quote & News

Company Profile

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, e...

Industry: Medical Care Facilities

Sector: Healthcare

Phone: 602 767 2100

Website: lifestance.com

Address:

4800 North Scottsdale Road, Suite 2500, Scottsdale, United States

JarvisFlow Dec. 12 at 10:30 AM

BTIG has adjusted their stance on LifeStance Health Gr ( $LFST ), setting the rating to Buy with a target price of 9 → 10.

0 · Reply

BillionerOfKing Dec. 12 at 1:41 AM

$LFST Current Stock Price: $6.78 Contracts to trade: $5 LFST Dec 19 2025 Call Entry: $1.70 Exit: $3.31 ROI: 95% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

setuphunter_11 Dec. 10 at 6:56 PM

$LFST

0 · Reply

JarvisFlow Dec. 9 at 3:01 PM

Barclays has updated their rating for LifeStance Health Gr ( $LFST ) to Overweight with a price target of 8.

0 · Reply

johnjaha Nov. 21 at 3:48 PM

$LFST

0 · Reply

BEATOFtheMARKET Nov. 17 at 12:54 AM

$LFST $LITE $LLY $LMND $LOCO

0 · Reply

JarvisFlow Nov. 13 at 9:53 AM

BMO Capital has updated their rating for LifeStance Health Gr ( $LFST ) to Outperform with a price target of 8.

0 · Reply

Winning_calls Nov. 10 at 3:58 AM

$LFST pick me up @ $6.35

1 · Reply

BioTechHealthX Nov. 9 at 6:51 AM

$LFST LifeStance Health Group revenue is up 16% to $363.8 M in Q3 vs $312.7 M a year ago — stock jumps as profitability returns. Check this out! https://biotechhealthx.com/biotech-news/lifestance-lfst-soars-nearly-30-after-q3-2025-revenue-hits-363-8m/

0 · Reply

JarvisFlow Nov. 7 at 4:30 PM

UBS updates rating for LifeStance Health Gr ( $LFST ) to Buy, target set at 9 → 10.

0 · Reply

LifeStance Health Group, Inc. (LFST) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 6:00 AM EST - 6 weeks ago

LifeStance Reports Third Quarter 2025 Results

Nov 5, 2025, 9:00 AM EST - 7 weeks ago

Nearly 7 in 10 Americans Feel Pressure to Appear Happier Than They Are This Holiday Season

Oct 28, 2025, 4:10 PM EDT - 2 months ago

LifeStance to Present at the UBS Global Healthcare Conference

Oct 28, 2025, 9:00 AM EDT - 2 months ago

Calm Health Partners with LifeStance Health to Help Users Access High-Quality Mental Health Care

Oct 16, 2025, 4:10 PM EDT - 2 months ago

LifeStance to Host Third Quarter 2025 Earnings Conference Call on November 6, 2025

Sep 9, 2025, 12:18 PM EDT - 3 months ago

LifeStance Health Group, Inc. (LFST) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Aug 26, 2025, 4:10 PM EDT - 4 months ago

LifeStance to Present at the 23rd Annual Morgan Stanley Healthcare Conference

Aug 22, 2025, 9:00 AM EDT - 4 months ago

Sarah Personette Appointed to LifeStance Board of Directors

Aug 8, 2025, 2:02 AM EDT - 4 months ago

LifeStance Health Group, Inc. (LFST) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 6:00 AM EDT - 4 months ago

LifeStance Reports Second Quarter 2025 Results

Jul 22, 2025, 9:00 AM EDT - 5 months ago

'Stressflation' is Here: 83% of Americans Say Today's Economic Climate is Taking a Toll on Their Mental Health

Jul 17, 2025, 4:10 PM EDT - 5 months ago

LifeStance to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025

Jul 3, 2025, 11:40 AM EDT - 6 months ago

LifeStance: First Profit, Expanding Margins, And Hybrid Model Make It A Buy Despite Valuation Concerns

May 28, 2025, 4:10 PM EDT - 7 months ago

LifeStance to Present at the 46th Annual Goldman Sachs Healthcare Conference

May 14, 2025, 9:00 AM EDT - 8 months ago

LifeStance Names Vaughn Paunovich as Chief Technology Officer

May 10, 2025, 2:22 PM EDT - 8 months ago

LifeStance Health Group, Inc. (LFST) Q1 2025 Earnings Call Transcript

May 7, 2025, 6:00 AM EDT - 8 months ago

LifeStance Reports First Quarter 2025 Results

Apr 22, 2025, 6:12 AM EDT - 8 months ago

LifeStance Health Group: Solid Execution Drives Growth And Margin Expansion

Apr 21, 2025, 4:10 PM EDT - 8 months ago

LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025

Feb 28, 2025, 9:31 AM EST - 10 months ago

LifeStance Health Group, Inc. (LFST) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 6:02 AM EST - 10 months ago

LifeStance Appoints Dave Bourdon as CEO; Ken Burdick Named Executive Chairman

Feb 27, 2025, 6:00 AM EST - 10 months ago

LifeStance Reports Fourth Quarter and Full Year 2024 Results

Feb 6, 2025, 4:10 PM EST - 11 months ago

LifeStance to Host Fourth Quarter and Full Year 2024 Earnings Conference Call on February 27, 2025

Nov 20, 2024, 9:00 AM EST - 1 year ago

Zarminali Health Launches with $40M in Seed Funding to Transform Pediatric Care through Nationwide, Multi-specialty Practice Group

Nov 8, 2024, 6:21 PM EST - 1 year ago

LifeStance Health Group, Inc. (LFST) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 6:00 AM EST - 1 year ago

LifeStance Reports Third Quarter 2024 Results

Oct 17, 2024, 4:10 PM EDT - 1 year ago

LifeStance to Host Third Quarter 2024 Earnings Conference Call on November 7, 2024

Oct 8, 2024, 9:00 AM EDT - 1 year ago

LifeStance Survey Finds 79% of Americans Are Experiencing Anxiety Over the 2024 U.S. Presidential Election

Aug 22, 2024, 8:49 AM EDT - 1 year ago

LifeStance Health Group: Long-Term Growth With Adj. EBITDA Margin Inflection Upwards

Aug 21, 2024, 4:10 PM EDT - 1 year ago

LifeStance to Present at the 22nd Annual Morgan Stanley Healthcare Conference

Aug 19, 2024, 9:00 PM EDT - 1 year ago

Bragar Eagel & Squire, P.C. Is Investigating LifeStance and Customers Bancorp and Encourages Investors to Contact the Firm

CUBI

Aug 8, 2024, 1:06 PM EDT - 1 year ago

LifeStance Health Group, Inc. (LFST) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 6:00 AM EDT - 1 year ago

LifeStance Reports Second Quarter 2024 Results

Jul 30, 2024, 10:00 AM EDT - 1 year ago

The Schall Law Firm Investigates Claims On Behalf Of Investors Of Qualys Inc And Encourages Investors With Losses To Contact The Firm

Jul 26, 2024, 4:30 PM EDT - 1 year ago

The Schall Law Firm Examines LifeStance Health Group Inc And Urges Impacted Investors To Engage In Dialogue

Jul 22, 2024, 4:15 PM EDT - 1 year ago

The Schall Law Firm Is Examining LifeStance Health Group Inc And Encourages Impacted Investors To Initiate Dialogue

Jul 19, 2024, 8:00 PM EDT - 1 year ago

The Schall Law Firm Is Examining LifeStance Health Group Inc And Urges Impacted Investors To Begin Dialogue

Jul 18, 2024, 5:10 PM EDT - 1 year ago

LifeStance Health Group Inc Is Under The Schall Law Firm's Scrutiny And Affected Investors Are Encouraged To Initiate Conversations

Jul 18, 2024, 4:10 PM EDT - 1 year ago

LifeStance to Host Second Quarter 2024 Earnings Conference Call on August 8, 2024

Jul 17, 2024, 3:15 PM EDT - 1 year ago

LifeStance Health Group Inc Is Under Examination By The Schall Law Firm, Affected Investors Are Encouraged To Initiate Conversations

Jul 16, 2024, 2:30 PM EDT - 1 year ago

The Schall Law Firm Urges Impacted Investors To Start Dialogue, LifeStance Health Group Inc Is Under Scrutiny

Jul 15, 2024, 3:00 PM EDT - 1 year ago

LifeStance Health Group Inc Under Investigation By The Schall Law Firm Encouraging Affected Investors To Initiate Conversation

Jul 13, 2024, 7:00 PM EDT - 1 year ago

LifeStance Health Group Inc Under Investigation By The Schall Law Firm Encourages Affected Investors To Start Conversation

Jul 12, 2024, 6:30 PM EDT - 1 year ago

The Schall Law Firm Is Investigating LifeStance Health Group Inc And Invites Impacted Investors To Begin Dialogue

JarvisFlow Dec. 12 at 10:30 AM

BTIG has adjusted their stance on LifeStance Health Gr ( $LFST ), setting the rating to Buy with a target price of 9 → 10.

0 · Reply

BillionerOfKing Dec. 12 at 1:41 AM

0 · Reply

setuphunter_11 Dec. 10 at 6:56 PM

$LFST

0 · Reply

JarvisFlow Dec. 9 at 3:01 PM

Barclays has updated their rating for LifeStance Health Gr ( $LFST ) to Overweight with a price target of 8.

0 · Reply

johnjaha Nov. 21 at 3:48 PM

$LFST

0 · Reply

BEATOFtheMARKET Nov. 17 at 12:54 AM

$LFST $LITE $LLY $LMND $LOCO

0 · Reply

JarvisFlow Nov. 13 at 9:53 AM

BMO Capital has updated their rating for LifeStance Health Gr ( $LFST ) to Outperform with a price target of 8.

0 · Reply

Winning_calls Nov. 10 at 3:58 AM

$LFST pick me up @ $6.35

1 · Reply

BioTechHealthX Nov. 9 at 6:51 AM

0 · Reply

JarvisFlow Nov. 7 at 4:30 PM

UBS updates rating for LifeStance Health Gr ( $LFST ) to Buy, target set at 9 → 10.

0 · Reply

JarvisFlow Nov. 7 at 9:14 AM

BTIG has adjusted their stance on LifeStance Health Gr ( $LFST ), setting the rating to Buy with a target price of 8 → 9.

0 · Reply

lenten Nov. 6 at 10:14 PM

$ASST $IOVA $FSLY $LFST $BGS

0 · Reply

GSP Nov. 6 at 10:04 PM

$ASST $IOVA $FSLY $LFST $BGS

0 · Reply

RunnerSignals Nov. 6 at 9:19 PM

Movers & Shakers Mayhem 🚀 $FRGE $FSLY $HAE $APPN $LFST all on fire today! but which one the real breakout? https://stocksrunner.com/news/2025-11-06-top-5-movers-and-shakers-today-steal-the-buzz

0 · Reply

Ld149 Nov. 6 at 8:27 PM

$LFST keep moving baby!!!

0 · Reply

Alidrisi Nov. 6 at 6:49 PM

$LFST

1 · Reply

dbr_island Nov. 6 at 2:35 PM

$LFST there it goes…. NUAI you ignored me here in the .40’s ✅ DTCK you ignored me here in the .70’s ✅ NVTS you ignored me here in the $4’s ✅ ABAT you ignored me here in the .90’s ✅ DO NOT IGNORE SPHL 👈 🚨🚨🚨 This is the next MTC imo

0 · Reply

Ld149 Nov. 6 at 1:36 PM

$LFST good! now get to $9

0 · Reply

Defen Oct. 14 at 9:37 AM

$LFST got out of this one even so it should go up now Too much inside selling

0 · Reply

Ld149 Oct. 13 at 2:14 PM

$LFST they just got upgraded to strong buy and this drops like a brick?

0 · Reply

Defen Oct. 10 at 12:13 PM

$LFST why so much inside selling?

2 · Reply

Market Cap	2.75B
Revenue (ttm)	1.25B
Net Income (ttm)	-57.44M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-4.59%
Debt to Equity Ratio	0.18

Volume	728,300
Avg Vol	2,255,836
Day's Range	N/A - N/A
Shares Out	389.00M
Stochastic %K	85%
Beta	1.13
Analysts	Strong Sell
Price Target	$8.55